Wegovy Shortage 2026: Where to Get Semaglutide Now
Complete guide covering Wegovy supply shortages and semaglutide access in 2026. Compare options, understand pricing, and see how compounded GLP-1 medications from licensed pharmacies fit into the picture.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. This article provides comprehensive, medically reviewed information about Wegovy supply shortages and semaglutide access to help patients make informed treatment decisions.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Understanding Wegovy Shortage 2026
This article examines Wegovy supply shortages and semaglutide access in the context of this evolving market, providing patients with the information they need to evaluate their options and make decisions that align with their health goals and financial reality. Whether you are considering semaglutide or tirzepatide, understanding the current landscape is essential for making an informed choice.
Frequently Asked Questions
What should patients know about Wegovy supply shortages and semaglutide access?
Patients exploring GLP-1 medications for weight loss in 2026 have more options than ever. Brand-name medications like Wegovy, Ozempic, Mounjaro, and Zepbound have proven clinical effectiveness but carry retail prices of $900 to $1,500 per month. Compounded semaglutide and compounded tirzepatide are available through telehealth providers like Trimi starting at $99 to $149 per month, making treatment accessible to millions more patients.
How do compounded GLP-1 medications compare to brand-name options?
Brand-name GLP-1s such as Wegovy, Ozempic, Mounjaro, and Zepbound are FDA-approved products manufactured by Novo Nordisk and Eli Lilly. Compounded semaglutide and compounded tirzepatide are prepared by licensed compounding pharmacies per individual prescription and are not FDA-approved as drugs. The practical differences for patients are the source, the delivery device (a vial and syringe rather than a pre-filled pen), and the monthly price.
Is compounded semaglutide or tirzepatide safe?
Compounded GLP-1 medications from accredited pharmacies are generally considered safe. They are prepared per individual prescription and are not FDA-approved as drugs. Quality depends on the compounding pharmacy, patients should choose providers that partner with PCAB-accredited or FDA-registered 503A community sterile-compounding pharmacy that conduct third-party potency and sterility testing. Trimi meets all of these quality standards.
How much does compounded GLP-1 treatment cost through Trimi?
Through Trimi, compounded semaglutide starts at $99 per month and compounded tirzepatide starts at $125 per month. Pricing is flat and published up front, and it covers the clinical evaluation, ongoing provider support, and the medication itself, so you can work out the full twelve-month cost, $1,188 for semaglutide or $1,500 for tirzepatide, before you start. No insurance, prior authorization, or separate consultation fee is required.
Do I need insurance to get compounded GLP-1 medications?
No, compounded GLP-1 medications through Trimi do not require insurance coverage. Treatment is available at transparent monthly prices with no prior authorization, no coverage denials, and no formulary restrictions. This makes compounded options particularly valuable for uninsured patients, those on Medicare or Medicaid, and those whose insurance does not cover weight loss medications.
How do I get started with compounded GLP-1 treatment?
Through Trimi, the process starts with an online health assessment covering your medical history, medications, and weight loss goals. A board-certified provider reviews your information, typically within 24 hours, and prescribes the appropriate medication if clinically appropriate. Your medication is prepared by an accredited compounding pharmacy and shipped free overnight to your door once compounded.
Can I switch from a brand-name medication to compounded?
Switching is a clinical decision, so start by telling your provider exactly what you are taking now, at what dose, and when your last injection was. If they decide a compounded preparation is appropriate for you, they will set the dose and the titration schedule, including whether any adjustment is needed. Compounded preparations are made against an individual prescription, are not FDA-approved as drugs, and have not been studied in clinical trials of their own, so never change or stop a prescribed medication on your own.
Sources & References
- STEP 1 trial: semaglutide 2.4mg for weight management (NEJM, 2021).
- SURMOUNT-1 trial: tirzepatide for obesity (NEJM, 2022).
- FDA guidance on drug compounding regulations.
- FDA drug shortage database.
- NABP compounding pharmacy accreditation standards.
- NIDDK overview of prescription weight loss medications.
- Wegovy prescribing information from the FDA.
- Zepbound prescribing information from the FDA.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Trimi provides compounded GLP-1 medications, this article aims to be informative and balanced, but readers should be aware of our perspective.